V

vTv Therapeutics
D

VTVT

15.300
USD
0.32
(2.14%)
مغلق
حجم التداول
13
الربح لكل سهم
-3
العائد الربحي
-
P/E
-5
حجم السوق
40,043,390
أصول ذات صلة
C
CVM
-0.06000
(-2.38%)
2.46000 USD
P
PRPO
1.750
(15.56%)
13.000 USD
V
VSTM
-0.05500
(-1.13%)
4.81500 USD
V
VTVT
0.320
(2.14%)
15.300 USD
المزيد
الأخبار المقالات

العنوان: vTv Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.